Rating
Buy
Price target
$525
Previous
$500
Implied upside
+24%
vs $421.86 prior close

Since this note−16% AVGO $421.86 → $352.53 (Oct 2) · moving away from the target

Aletheia Capital analyst Stefan Chang raised the price target on Broadcom Limited (NASDAQ: AVGO) to $525.00 (from $500.00) while maintaining a Buy rating.

“AVGO will report F2Q result and F3Q guidance on 3 June after trading hours. We believe the near-term numbers are less important than the company’s comments on TPU.

We believe Google has reshuffled its inferencing TPU plan to use TPUv8i (and possibly TPUv8i+) for 2027/28E. Whether AVGO’s next-gen TPU (likely called Merope) will be pulled in remains to be seen.

From a numbers’ perspective, we do not see any downside risk to our F26/27E revenue and earnings, thanks to strong inferencing demand and rising networking value.

However, if we are proven right that AVGO will skip TPUv9 (while MTK will not), AVGO’s value proposition to Google and its valuation multiple will need a revisit.

We maintain a BUY rating on AVGO and raise our TP from $500 to $525; this is based on higher F27E earnings but lower P/E target (from 28x to 25x) to factor in the rising uncertainties.

Upside risks include rising inferencing demand, while the key downside risk is Google’s pace for its COT adoption.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.